Congress Urges HHS to Ease Up Restrictions on Marijuana Research

Currently, marijuana is still listed as a Schedule I substance in the U.S., meaning that scientists have to seek permission from the DEA and get state and local licenses that allow them to possess the drug before testing it. This prevents a vast amount of studies that could, and many argue, should be going into the drug.

With more than 22 states allowing the use of marijuana for medical purposes today, and more than 1 million Americans currently using it as treatment, 30 members of Congress are now pushing for federal policies that would help ramp up research, not roadblock it.

Newsfeed: Advocates Claim HIV Discrimination by Florida Health Insurers. Have filed a legal complaint with HHS. Four health insurance companies in Florida have put HIV drugs on their most expensive tiers to purposely discourage enrollment by people living with the virus.

Newsfeed: Advocates Claim HIV Discrimination by Florida Health Insurers. Have filed a legal complaint with HHS.

Four health insurance companies in Florida have put HIV drugs on their most expensive tiers to purposely discourage enrollment by people living with the virus.

POZ Opinion: Reevaluate the FDA Gay Blood Ban
A gay California mayor wants to stop discrimination against gay men who want to donate blood:
"The ban was imposed in 1983 when there were no reliable tests for screening blood for HIV/AIDS. It was also made during a time of mass medical confusion and cultural homophobia associated with HIV/AIDS. The current FDA ban is wildly outdated and perpetuates unfair labels against gay and bisexual men that live on through decades of discrimination."

POZ Opinion: Reevaluate the FDA Gay Blood Ban

A gay California mayor wants to stop discrimination against gay men who want to donate blood:

"The ban was imposed in 1983 when there were no reliable tests for screening blood for HIV/AIDS. It was also made during a time of mass medical confusion and cultural homophobia associated with HIV/AIDS. The current FDA ban is wildly outdated and perpetuates unfair labels against gay and bisexual men that live on through decades of discrimination."

Preparing for Generics in the U.S.With patent expirations pending over the next four to five years for several Department of Health and Human Services (HHS)-preferred and -alternative ARVs,* attention to the potential for cost savings—along with the safety, efficacy and convenience of generic options to be made available in the U.S.—is now critical.

Preparing for Generics in the U.S.
With patent expirations pending over the next four to five years for several Department of Health and Human Services (HHS)-preferred and -alternative ARVs,* attention to the potential for cost savings—along with the safety, efficacy and convenience of generic options to be made available in the U.S.—is now critical.